With advances in global medical technology, occupational safety for healthcare workers has become increasingly important, especially concerning the risk of needlestick injuries and infections from reused syringes. Many countries have gradually legislated to promote the use of safety syringes as replacements for traditional syringes, making it a major trend in the healthcare industry worldwide.
In the United States, as early as November 6, 2000, the federal government passed the U.S. Safe Medical Devices Act, which prompted states to implement laws protecting healthcare workers. To date, 44 states have passed mandatory legislation. Additionally, Canada began promoting safety syringes in 2006, and Brazil enacted a corresponding law at the end of 2008, mandating the use of safety syringes across the country. Internationally, in 1997, the World Health Organization (WHO), UNICEF, and other agencies signed an agreement with 73 countries to ensure the use of safety or self-destruct syringes for children's immunizations, replacing conventional syringes.
Taiwan has also taken steps in this direction. According to Article 52, Section 2 of the Medical Care Act, since 2012, medical institutions have been required to provide safety syringes for healthcare professionals. By 2016, the use of safety syringes was mandated across Taiwan, significantly enhancing healthcare worker safety and reducing infection risks. However, the massive demand for vaccine injections brought on by the COVID-19 pandemic has led to a severe global shortage of syringes. On November 9, 2021, WHO warned of a possible shortfall of 2 billion syringes, potentially reaching 6 billion by 2023, which would severely impact the speed of vaccine delivery and the safety of syringe supplies.
In terms of market demand, the U.S., Europe, and Japan are currently the primary producers of safety syringes. In 2021 alone, the U.S. produced 12.511 billion safety syringes, accounting for 49.37% of the global market, making it the leading producer. In the same year, China's production reached 1.581 billion syringes, with 894 million exported to other countries. At present, Taiwan relies heavily on imports of safety syringes from the U.S. and China. However, this presents new opportunities for local Taiwanese companies.
With the growing global demand for safety syringes, Taiwan should actively invest in this field. The development and production of high-standard safety syringes in Taiwan will be a crucial step toward establishing a foothold in the global market. This will not only fulfill domestic needs but also provide high-quality injection equipment to the global market, enhancing Taiwan's competitiveness in the international medical device sector.
In conclusion, the global trend toward safety syringes is well-established, and Taiwan has the potential to become a key player in this market. Through innovative technology and high-standard production, Taiwan’s safety syringe products can contribute significantly to healthcare worker safety and public health worldwide.
